- Works count
- 1,310
- Citation count
- 57,121
- H-index
- 103
- i10-index
- 737
Research interests
Publications
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
Current Issues in Molecular Biology · 2023 · 10.3390/cimb45080420
p53 signaling in cancer progression and therapy
Cancer Cell International · 2021 · 10.1186/s12935-021-02396-8
Role of p53 in the Regulation of Cellular Senescence
Biomolecules · 2020 · 10.3390/biom10030420
Curcumin and Cancer
Nutrients · 2019 · https://doi.org/10.3390/nu11102376
Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures
Clinical Journal of Pain · 2018 · 10.1097/ajp.0000000000000599
Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation
Journal of Lipid Research · 2018 · 10.1194/jlr.m079665
Virtual Reality in Health System: Beyond Entertainment. A Mini‐Review on the Efficacy of VR During Cancer Treatment
Journal of Cellular Physiology · 2015 · 10.1002/jcp.25117
Cell cycle kinases as therapeutic targets for cancer
Nature Reviews Drug Discovery · 2009 · https://doi.org/10.1038/nrd2907
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.11.3787
From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells
Journal of Cellular Physiology · 2007 · 10.1002/jcp.20959
RB and cell cycle progression
Oncogene · 2006 · https://doi.org/10.1038/sj.onc.1209615
Smart materials as scaffolds for tissue engineering
Journal of Cellular Physiology · 2005 · 10.1002/jcp.20270
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
Endocrine Related Cancer · 2005 · 10.1677/erc.1.00857
Advantages and limitations of microarray technology in human cancer
Oncogene · 2003 · 10.1038/sj.onc.1206865
From Cell–ECM interactions to tissue engineering
Journal of Cellular Physiology · 2003 · 10.1002/jcp.10471
Cell Cycle and Apoptosis
Neoplasia · 2000 · 10.1038/sj.neo.7900101
p300 and CBP: Partners for life and death
Journal of Cellular Physiology · 1999 · 10.1002/(sici)1097-4652(199911)181:2<218::aid-jcp4>3.0.co;2-5
p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription
The EMBO Journal · 1997 · 10.1093/emboj/16.2.369
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
PubMed · 1997
Simian virus-40 large-T antigen binds p53 in human mesotheliomas
Nature Medicine · 1997 · 10.1038/nm0897-908
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Cell · 1997 · https://doi.org/10.1016/s0092-8674(00)80304-9
Human p300 Protein Is a Coactivator for the Transcription Factor MyoD
Journal of Biological Chemistry · 1996 · 10.1074/jbc.271.15.9009
Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and Cancer
Critical Reviews in Eukaryotic Gene Expression · 1995 · 10.1615/critreveukargeneexpr.v5.i2.20
Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
Science · 1992 · https://doi.org/10.1126/science.1388288
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells
Cell · 1989 · 10.1016/0092-8674(89)90949-5
Current projects
No projects listed.